These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24370490)

  • 1. Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescents.
    Obioha O; Adesman A
    Curr Opin Pediatr; 2014 Feb; 26(1):119-29. PubMed ID: 24370490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical diagnosis and management of attention deficit hyperactivity disorder in preschool children.
    Kaplan A; Adesman A
    Curr Opin Pediatr; 2011 Dec; 23(6):684-92. PubMed ID: 22045309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
    Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
    Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Pliszka S;
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):894-921. PubMed ID: 17581453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
    Wolraich ML; Wibbelsman CJ; Brown TE; Evans SW; Gotlieb EM; Knight JR; Ross EC; Shubiner HH; Wender EH; Wilens T
    Pediatrics; 2005 Jun; 115(6):1734-46. PubMed ID: 15930238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of attention-deficit/hyperactivity disorder: the importance of psychosocial and medication treatments.
    Vance A; Winther J; Rennie K
    J Paediatr Child Health; 2012 Feb; 48(2):E33-7. PubMed ID: 21244547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinican's guide to adult attention-deficit hyperactivity disorder.
    Modesto-Lowe V; Meyer A; Soovajian V
    Conn Med; 2012 Oct; 76(9):517-23. PubMed ID: 23155670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The child with ADHD: using the AAP Clinical Practice Guideline. American Academy of Pediatrics.
    Herrerias CT; Perrin JM; Stein MT
    Am Fam Physician; 2001 May; 63(9):1803-10. PubMed ID: 11352293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
    Bukstein O
    Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives.
    Al-Ghamdy YS; Qureshi NA
    Saudi Med J; 2001 Aug; 22(8):666-73. PubMed ID: 11573110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit/hyperactivity disorder: a review and update.
    Cormier E
    J Pediatr Nurs; 2008 Oct; 23(5):345-57. PubMed ID: 18804015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
    Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
    Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.